• Please log in or register to access this feature.

Epidemiology

You have full text access to this OnlineOpen article

Relationship of hepatocellular carcinoma to soya food consumption: A cohort-based, case-control study in Japan

  1. Gerald B. Sharp1,2,†,*,
  2. Frederic Lagarde2,3,
  3. Terumi Mizuno4,
  4. Catherine Sauvaget1,2,
  5. Toshiyuki Fukuhara5,
  6. Naomi Allen6,
  7. Gen Suzuki7,
  8. Shoji Tokuoka8

Article first published online: 1 FEB 2005

DOI: 10.1002/ijc.20897

Issue

International Journal of Cancer

International Journal of Cancer

Volume 115, Issue 2, pages 290–295, 1 June 2005

Additional Information

How to Cite

Sharp, G. B., Lagarde, F., Mizuno, T., Sauvaget, C., Fukuhara, T., Allen, N., Suzuki, G. and Tokuoka, S. (2005), Relationship of hepatocellular carcinoma to soya food consumption: A cohort-based, case-control study in Japan. Int. J. Cancer, 115: 290–295. doi: 10.1002/ijc.20897

Author Information

  1. 1

    Department of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan

  2. 2

    National Academy of Sciences, Washington, D.C., USA

  3. 3

    Department of Statistics, Radiation Effects Research Foundation, Hiroshima, Japan

  4. 4

    Department of Radiobiology and Molecular Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan

  5. 5

    Department of Pathology, Hiroshima Prefectural Hospital, Hiroshima, Japan

  6. 6

    Epidemiology Unit, Cancer Research UK, Oxford University, Oxford, UK

  7. 7

    Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan

  8. 8

    Consultant, Radiation Effects Research Foundation, Hiroshima, Japan

  1. †

    Fax: +301-402-3211.

*Epidemiology Branch, Basic Sciences Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 6700-B Rockledge Dr., Rm. 4103, Bethesda, MD 20892, USA

  1. †

    Fax: +301-402-3211.

Publication History

  1. Issue published online: 21 MAR 2005
  2. Article first published online: 1 FEB 2005
  3. Manuscript Accepted: 17 NOV 2004
  4. Manuscript Received: 25 JUN 2004

Funded by

  • Radiation Effects Research Foundation. Grant Numbers: 5-90, 1-99
  • U.S. National Institutes of Health. Grant Number: NCI-4893-8-001
  • Japanese Ministry of Education, Culture, Sports, Science, and Technology. Grant Number: 15026220

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (97K)

References

  • 1
    Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998; 75: 347–54.
    Direct Link:
  • 2
    Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, Hsiao TJ, Lin SM, Lee SD, Chen PJ, Liu CJ, Chen CJ. Androgen-receptor gene CAG repeats,plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 2000; 92: 2023–8.
  • 3
    Tanaka K, Sakai H, Hashizume M, Hirohata T. Serum testosterone: estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Res 2000; 60: 5106–10.
  • 4
    Tavani A, Negri E, Parazzini F, Franceschi S, La Vecchia C. Female hormone utilisation and risk of hepatocellular carcinoma. Br J Cancer 1993; 67: 635–7.
  • 5
    Trichopoulos D. Etiology of primary liver cancer and the role of steroidal hormones. Cancer Causes Control 1992; 3: 3–5.
  • 6
    Mucci LA, Kuper HE, Tamimi R, Lagiou P, Spanos E, Trichopoulos D. Age at menarche and age at menopause in relation to hepatocellular carcinoma in women. BJOG 2001; 108: 291–4.
  • 7
    PeetersPH, Keinan-BokerL, van der SchouwYT, GrobbeeDE, eds. Phytoestrogens and breast cancer risk: review of the epidemiological evidence. IARC Sci Publ 156. Lyon: IARC, 2002; 331–6.
  • 8
    Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 2002; 132: 3168–71.
  • 9
    Su SJ, Chow NH, Kung ML, Hung TC, Chang KL. Effects of soy isoflavones on apoptosis induction and G2–M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr Cancer 2003; 45: 113–23.
  • 10
    Sonoda T, Nagata Y, Mori M, Miyanaga N, Takashima N, Okumura K, Goto K, Naito S, Fujimoto K, Hirao Y, Takahashi A, Tsukamoto T, et al. A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci 2004; 95: 238–42.
    Direct Link:
  • 11
    Xu WH, Zheng W, Xiang YB, Ruan ZX, Cheng JR, Dai Q, Gao YT, Shu XO. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ 2004; 328: 1285–9.
  • 12
    Adlercreutz H. Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 2002; 83: 113–18.
  • 13
    Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast-cancer risk in Singapore. Lancet 1991; 337: 1197–200.
  • 14
    Lei B, Roncaglia V, Vigano R, Cremonini C, De Maria N, Del Buono MG, Manenti F, Villa E. Phytoestrogens and liver disease. Mol Cell Endocrinol 2002; 193: 81–4.
  • 15
    Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13. Solid cancer and noncancer disease mortality: 1950–1997. Radiat Res 2003; 160: 381–407.
  • 16
    Mabuchi K, Soda M, Ron E, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Preston DL, Thompson DE. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res 1994; 137: S1–16.
  • 17
    Sharp GB, Cologne JB, Fukuhara T, Itakura H, Yamamoto M, Tokuoka S. Temporal changes in liver cancer incidence rates in Japan: accounting for death certificate inaccuracies and improving diagnostic techniques. Int J Cancer 2001; 93: 751–8.
    Direct Link:
  • 18
    Fukuhara T, Sharp GB, Mizuno T, Itakura H, Yamamoto M, Tokunaga M, Tokuoka S, Cologne JB, Fujita Y, Soda M, Mabuchi K. Liver cancer in atomic-bomb survivors: histological characteristics and relationships to radiation and hepatitis B and C viruses. J Radiat Res (Tokyo) 2001; 42: 117–30.
  • 19
    Gibson JB, Sobin LH. Histological typing of tumours of the liver, biliary tract and pancreas. International histological classification of tumours. Geneva: WHO, 1978.
  • 20
    Shikata T, Uzawa T, Yoshiwara N, Akatsuka T, Yamazaki S. Staining methods of Australia antigen in paraffin section—detection of cytoplasmic inclusion bodies. Jpn J Exp Med 1974; 44: 25–36.
  • 21
    Iwamoto KS, Mizuno T, Ito T, Akiyama M, Takeichi N, Mabuchi K, Seyama T. Feasibility of using decades-old archival tissues in molecular oncology/epidemiology. Am J Pathol 1996; 149: 399–406.
  • 22
    Mizuno T, Nagamura H, Iwamoto KS, Ito T, Fukuhara T, Tokunaga M, Tokuoka S, Mabuchi K, Seyama T. RNA from decades-old archival tissue blocks for retrospective studies. Diagn Mol Pathol 1998; 7: 202–8.
  • 23
    Sauvaget C, Allen N, Hayashi M, Spencer E, Nagano J. Validation of a food frequency questionnaire in the Hiroshima/Nagasaki Life Span Study. J Epidemiol 2002; 12: 394–401.
  • 24
    Goodman MT, Moriwaki H, Vaeth M, Akiba S, Hayabuchi H, Mabuchi K. Prospective cohort study of risk factors for primary liver cancer in Hiroshima and Nagasaki, Japan. Epidemiology 1995; 6: 36–41.
  • 25
    Chiba T, Matsuzaki Y, Abei M, Shoda J, Tanaka N, Osuga T, Aikawa T. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus–related hepatocellular carcinoma. Am J Gastroenterol 1996; 91: 1195–203.
  • 26
    El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745–50.
  • 27
    Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065–7.
  • 28
    De Maria N, Manno M, Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol 2002; 193: 59–63.
  • 29
    Vesselinovitch SD, Mihailovich N. The effect of gonadectomy on the development of hepatomas induced by urethane. Cancer Res 1967; 27: 1788–91.
  • 30
    Chao Y, Chan WK, Huang YS, Teng HC, Wang SS, Lui WY, Whang-Peng J, Lee SD. Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer 1996; 77: 635–9.
    Direct Link:
  • 31
    Grimaldi C, Bleiberg H, Gay F, Messner M, Rougier P, Kok TC, Cirera L, Cervantes A, De Greve J, Paillot B, Buset M, Nitti D, et al. Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial. J Clin Oncol 1998; 16: 411–417.
  • 32
    Farinati F, De Maria N, Marafin C, Fagiuoli S, Della LG, Naccarato R. Hepatocellular carcinoma in alcoholic cirrhosis: is sex hormone imbalance a pathogenetic factor? Eur J Gastroenterol Hepatol 1995; 7: 145–50.
  • 33
    Nagasue N, Ogawa Y, Yukaya H, Ohta N, Ito A. Serum levels of estrogens and testosterone in cirrhotic men with and without hepatocellular carcinoma. Gastroenterology 1985; 88: 768–72.
  • 34
    CLIP Group. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. CLIP Group (Cancer of the Liver Italian Programme). Lancet 1998; 352: 17–20.
  • 35
    Yu MW, Chen CJ. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 1993; 15: 790–4.
  • 36
    Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, Chen CJ. Hormonal markers and hepatitis B virus–related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 2001; 93: 1644–51.
  • 37
    Villa E, Dugani A, Moles A, Camellini L, Grottola A, Buttafoco P, Merighi A, Ferretti I, Esposito P, Miglioli L, Bagni A, Troisi R, et al. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease. Hepatology 1998; 27: 983–8.
    Direct Link:
  • 38
    Hsing AW, Hoover RN, McLaughlin JK, Co-Chien HT, Wacholder S, Blot WJ, Fraumeni JFJr. Oral contraceptives and primary liver cancer among young women. Cancer Causes Control 1992; 3: 43–8.
  • 39
    Kumar NB, Cantor A, Allen K, Riccardi D, Cox CE. The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer 2002; 94: 1166–74.
    Direct Link:
  • 40
    Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994; 60: 333–40.
  • 41
    Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000; 27: 67–73.
  • 42
    Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA, Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999; 18: 4608–18.
  • 43
    Mokhtar NM, el Aaser AA, el Bolkainy MN, Ibrahim HA, el Din NB, Moharram NZ. Effect of soybean feeding on experimental carcinogenesis—III. Carcinogenicity of nitrite and dibutylamine in mice: a histopathological study. Eur J Cancer Clin Oncol 1988; 24: 403–11.
  • 44
    Park JH, Oh EJ, Choi YH, Kang CD, Kang HS, Kim DK, Kang KI, Yoo MA. Synergistic effects of dexamethasone and genistein on the expression of Cdk inhibitor p21WAF1/CIP1 in human hepatocellular and colorectal carcinoma cells. Int J Oncol 2001; 18: 997–1002.
  • 45
    Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995; 125: 790S–7S.
  • 46
    Kang LP, Qi LH, Zhang JP, Shi N, Zhang M, Wu TM, Chen J. Effect of genistein and quercetin on proliferation, collagen synthesis, and type I procollagen mRNA levels of rat hepatic stellate cells. Acta Pharmacol Sin 2001; 22: 793–6.
View Full Article (HTML) Get PDF (97K)